Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
CRSP
CRISPR Therapeutics AG
Last Price:
$57.53
Seasonality Move:
-4.74%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.9 | Buy |
| 20-day SMA: | 59.67 | Buy |
| 50-day SMA: | 53.16 | Buy |
| 200-day SMA: | 44.96 | Buy |
| 8-day EMA: | 55.92 | Buy |
| 20-day EMA: | 43.13 | Buy |
| 50-day EMA: | 24.5 | Buy |
| 200-day EMA: | 7.46 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.13 | Buy |
| Relative Strength Index (14 RSI): | 57.22 | Buy |
| Chaikin Money Flow: | -1077671 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.76 - 63.48) | Buy |
| Bollinger Bands (100): | (35.03 - 54.99) | Buy |
CRISPR Therapeutics AG Technical Analysis
| Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 59.73 while CRSP 8-day simple moving average is 56.90, which is a Buy signal.
-
The stock price of CRSP is 59.73 while CRISPR Therapeutics AG 20-day SMA is 59.67, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 53.16 while CRSP share price is 59.73, making it a Buy technically.
-
CRSP stock price is 59.73 and CRISPR Therapeutics AG 200-day simple moving average is 44.96, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
46
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $59.73. The Score for CRSP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5.4B
Price in USD:
59.73
Share Volume:
3.1M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
71.13
52-Week Low:
30.04
Sell
46
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 59.73 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 59.73 while CRSP 8-day exponential moving average is 55.92, which is a Buy signal.
-
The stock price of CRSP is 59.73 while CRISPR Therapeutics AG 20-day EMA is 43.13, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 24.50 while CRSP share price is 59.73, making it a Buy technically.
-
CRSP stock price is 59.73 and CRISPR Therapeutics AG 200-day simple moving average is 7.46, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.95 per share, and an increase next year of $1.42 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 14.13, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 57.22, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (54.76 - 63.48), which suggest CRISPR Therapeutics AG is a Buy
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (35.03 - 54.99), which suggest CRISPR Therapeutics AG is a Buy
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.